By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Sumitomo Corporation 

Harumi Island Triton Square Office Tower Y
8-11 Harumi 1-chome
Chuo-ku  Tokyo  104-8610  Japan
Phone: 81-3-5166-5000 Fax:




Dupont Pharmaceuticals Research Laboratories  Target implicated in osteoarthritis and rheumatoid arthritis

Company News
Sumitomo Corporation Proton Therapy System Clears FDA 510(k) 12/1/2013 10:01:04 PM
Oxford Finance Expands Capital Base with $460 Million Commitment From Sumitomo Corporation of America and Welsh, Carson, Anderson & Stowe 4/26/2011 10:07:43 AM
Sumitomo Corporation Named Exclusive Distribution and Sales Agent for Chiral Quest, Inc. 4/15/2008 8:14:59 AM
UCB Japan Co., Ltd. Announces Sales Channel Change Of Zyrtec Tablet In Japan10/19/2005 5:13:08 PM
DNA Chip Research, Sumitomo Bakelite Co-develop Innovative DNA Microarray10/19/2005 5:12:34 PM
Sumitomo Pharmaceuticals Co. Ltd. To Transfer Its Antitumor Antibiotic Sales To Nippon Kayaku Co., Ltd.10/19/2005 5:12:24 PM
Dainippon Pharmaceutical Buying Sumitomo In $2.2 Billion Stock Deal10/19/2005 5:12:18 PM
BioTime (BTX) Announces Agreement To Develop Hextend And PentaLyte In Japan10/19/2005 5:10:53 PM
Olympus Biomaterial Corp. To Take Over Sumitomo Pharmaceuticals Co. Ltd.'s Bone Replacement Material Business10/19/2005 5:10:20 PM
Dainippon Pharmaceutical And Sumitomo Pharmaceuticals Co. Ltd. Announce Details Of Upcoming Merger10/19/2005 5:09:54 PM